US investors are showing the highest level of interest in Chinese stocks in five years, and their return to China’s market is just “starting” despite some lingering reasons for caution, according to Morgan Stanley. More than 90 per cent of investors had “explicit willingness to increase their exposure to China’s market, the highest level since…
SciSparc Ltd. (Nasdaq: SPRC), a clinical-stage pharmaceutical company, announced that shareholders of both SciSparc and AutoMax Motors Ltd. have approved their proposed merger. The strategic reverse merger will result in SciSparc acquiring 100% of AutoMax’s share capital, with SciSparc shareholders retaining 50.01% ownership of the combined company….
Given these and other recent milestones, Peng says it’s realistic to think that at least one BCI system could gain approval in China by 2027. Minmin Luo, director of the Chinese Institute for Brain Research (CIBR) in Beijing, agrees that the country is well on its way to meeting the goals set out by the…
In this week’s edition of The Prototype, we look at SpaceX’s upcoming Starship test, new science heading to the international space station, a way to make older brains more youthful and more. To get The Prototype in your inbox, sign up here. On Sunday evening, SpaceX will attempt the tenth test of its Starship rocket,…
A pair of Hong Kong-listed mainland Chinese biotechnology firms are poised to turn a profit this year as their revenue from novel drugs finally outstrips costs related to research and development and marketing, according to analysts. “Chinese biotechs have matured significantly and are creating value for Chinese patients and government payers,” said Tony Ren, head…
Chinese biotech company Leads Biolabs has hit the Hong Kong stock exchange, snagging $189 million through an initial public offering on the HKEX. The Nanjing-based antibody aficionado plans to use the windfall first and foremost on clinical trials, the company said in a July 24 release. About $123 million will go to clinical research, with…
The Shanghai Composite index was barely changed, holding at 3,510.18. (Reuters pic) HONG KONG: China stocks gave up most of their gains and closed flat today, weighed down by a drop in bank shares, while Hong Kong shares held on to gains after a Goldman upgrade. At market close, the Shanghai Composite index was barely…
The European Union has unveiled sweeping plans to slash its reliance on China and reclaim control over critical sectors – from chemicals to pharmaceuticals and biotech – as it steps up its de-risking plans. On Wednesday the bloc unveiled three separate proposals – an action plan for the chemicals industry, a medical countermeasures strategy and…
Hong Kong should capitalise on the opportunities arising from US-China tensions to attract more talent to its academic and tech sectors, heads of the city’s top medical schools have said, ahead of a visit to the world’s largest biotechnology event in Boston. Representatives from the medical faculties of the University of Hong Kong (HKU) and…
Hong Kong-based venture capital firm ORI Capital plans to launch a new fund to invest in Chinese healthcare start-ups, as the domestic biotechnology industry experiences its own “DeepSeek moment”, its founder said in an interview. ORI, established in 2015 with two funds that primarily invest in global biotech start-ups, is in the process of raising…